Effects of H2-receptor antagonists on 3H-cimetidine binding and histamine-stimulation of cellular cAMP in isolated guinea pig gastric glands
- PMID: 2890783
- DOI: 10.1254/jjp.45.97
Effects of H2-receptor antagonists on 3H-cimetidine binding and histamine-stimulation of cellular cAMP in isolated guinea pig gastric glands
Abstract
3H-Cimetidine binding to plasma membranes of isolated guinea pig gastric glands was investigated, and the effects of five H2-receptor antagonists on 3H-cimetidine binding and histamine stimulation of cellular cAMP were compared. Of the five cations tested, Cu++ markedly increased specific 3H-cimetidine binding. 3H-Cimetidine had high affinity (Kd = 0.41 x 10(-6) M) and low affinity (Kd = 12.8 x 10(-6) M) binding sites. Cimetidine and etintidine were potent inhibitors of 3H-cimetidine binding, while famotidine, ranitidine and TZU-0460 were not. Histamine stimulation of cellular cAMP was competitively inhibited by H2-receptor antagonists yielding pA2 values of 6.41 for cimetidine, 6.82 for etintidine, 6.87 for ranitidine, 6.94 for TZU-0460 and 7.60 for famotidine. Because the KB value (log KB = -pA2) of 0.39 x 10(-6) M for cimetidine is close to the Kd value for the high affinity 3H-cimetidine binding site, it is presumed to represent a part of the H2-receptor, and the relative potency of etintidine against cimetidine in inhibiting 3H-cimetidine binding is similar to that in inhibiting histamine stimulation of cellular cAMP. These results suggest that imidazole-derived H2-receptor antagonists (cimetidine and etintidine) and non-imidazole H2-receptor antagonists (famotidine, ranitidine and TZU-0460) compete with histamine at different sites on the H2-receptor of the gastric glands.
Similar articles
-
Pharmacokinetic and pharmacodynamic properties of histamine H2-receptor antagonists. Relationship between intrinsic potency and effective plasma concentrations.Clin Pharmacokinet. 1991 Mar;20(3):218-36. doi: 10.2165/00003088-199120030-00004. Clin Pharmacokinet. 1991. PMID: 1673880 Review.
-
Inhibitory effect of etintidine (BL-5641), a new type of H2 receptor antagonist, on binding of [3H]-cimetidine to plasma membrane and histamine-stimulated cellular cAMP production in isolated guinea pig gastric glands.Gastroenterol Jpn. 1986 Apr;21(2):106-11. doi: 10.1007/BF02774827. Gastroenterol Jpn. 1986. PMID: 2872137
-
A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.J Pharmacol Exp Ther. 1983 Jan;224(1):171-9. J Pharmacol Exp Ther. 1983. PMID: 6129316
-
Effect of somatostatin and its analogs on histamine-stimulated cAMP production in isolated guinea pig gastric glands.Gastroenterol Jpn. 1985 Dec;20(6):543-7. doi: 10.1007/BF02774813. Gastroenterol Jpn. 1985. PMID: 2417908
-
A review of the animal pharmacology of ranitidine--a new, selective histamine H2-antagonist.Scand J Gastroenterol Suppl. 1981 Jun;69:1-9. Scand J Gastroenterol Suppl. 1981. PMID: 6119770 Review.
Cited by
-
Drugs and receptors. An overview of the current state of knowledge.Drugs. 1990 Nov;40(5):666-87. doi: 10.2165/00003495-199040050-00003. Drugs. 1990. PMID: 2292230 Review.
-
Pharmacokinetic and pharmacodynamic properties of histamine H2-receptor antagonists. Relationship between intrinsic potency and effective plasma concentrations.Clin Pharmacokinet. 1991 Mar;20(3):218-36. doi: 10.2165/00003088-199120030-00004. Clin Pharmacokinet. 1991. PMID: 1673880 Review.
-
Effects of antiulcer drugs on phosphatidylcholine synthesis in isolated guinea pig gastric glands.Dig Dis Sci. 1992 Oct;37(10):1593-9. doi: 10.1007/BF01296507. Dig Dis Sci. 1992. PMID: 1396007
-
JB-9322, a new selective histamine H2-receptor antagonist with potent gastric mucosal protective properties.Br J Pharmacol. 1995 May;115(1):57-66. doi: 10.1111/j.1476-5381.1995.tb16319.x. Br J Pharmacol. 1995. PMID: 7647984 Free PMC article.
-
Roxatidine acetate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic potential in peptic ulcer disease and related disorders.Drugs. 1991 Aug;42(2):240-60. doi: 10.2165/00003495-199142020-00006. Drugs. 1991. PMID: 1717223 Review.